Is SANA undervalued or overvalued?
As of 2025-03-19, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -6.85 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.28 USD, the upside of Sana Biotechnology Inc is -400.37%. This means that SANA is overvalued by 400.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.85 - -6.85 | -6.85 | -400.37% |
| P/E | (19.50) - (38.78) | (30.95) | -1457.3% |
| DDM - Stable | (7.38) - (20.20) | (13.79) | -704.8% |
| DDM - Multi | (6.17) - (13.37) | (8.47) | -471.5% |
| Market Cap (mil) | 618.46 |
| Beta | -0.23 |
| Outstanding shares (mil) | 271.25 |
| Enterprise Value (mil) | 491.46 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.86% |
| Cost of Debt | 5.00% |
| WACC | 7.77% |